Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Oh

Showing results (241-250 of 552) with videos related to

Pageof 56
Sort By:
Biochimica Et Biophysica Acta|December 22, 1998
Cecropins induce the hyperosmotic stress response in Escherichia coliJ T Oh, Y Cajal, P S Dhurjati, et al.
Kokyu to Junkan. Respiration & Circulation|July 1, 1993
[Electrocardiographic study of sinus bradycardia associated with enterohemorrhagic Escherichia coli O157: H7 infection]M Sanada, H Okano, S Yokota, et al.
Asia-Oceania Journal of Obstetrics and Gynaecology|March 1, 1994
Prenatal ultrasonographic diagnosis of congenital kyphosis due to anterior segmentation failureT B Song, Y H Kim, S T Oh, et al.
Anaesthesia|March 20, 2014
A randomised comparison of the i-gel™ and the Laryngeal Mask Airway Classic™ in infantsM-S Kim, J-T Oh, J Y Min, et al.
Brain Research|February 26, 2008
Rod differentiation factor NRL activates the expression of nuclear receptor NR2E3 to suppress the development of cone photoreceptorsEdwin C T Oh, Hong Cheng, Hong Hao, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 4, 2001
Extracellular-superoxide dismutase in cerebrospinal fluid from infants/childrenT Adachi, M Yamamoto, H Hara, et al.
Chemical & Pharmaceutical Bulletin|January 1, 1990
Lignified natural products as potential medicinal resources. I. Potentiation of hemolytic plaque-forming cell production in miceT Oh-Hara, Y Ikeda, H Sakagami, et al.
Molecules and Cells|June 13, 2000
Effects of Polycomb group mutations on the expression of Ultrabithorax in the Drosophila visceral mesodermS H Choi, C T Oh, S H Kim, et al.
Therapeutic Advances in Hematology|March 14, 2024
A phase I trial of pevonedistat in combination with ruxolitinib for the treatment of myelofibrosisTim Kong, Nicole Gaudin, Karyn Gordon, et al.
Blood Cancer Journal|October 3, 2015
Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinibA Zhou, E M Knoche, E K Engle, et al.
Pageof 56

Showing results (241-250 of 552) with videos related to

Sort By:
Pageof 56
Biochimica Et Biophysica Acta|December 22, 1998
Cecropins induce the hyperosmotic stress response in Escherichia coliJ T Oh, Y Cajal, P S Dhurjati, et al.
Kokyu to Junkan. Respiration & Circulation|July 1, 1993
[Electrocardiographic study of sinus bradycardia associated with enterohemorrhagic Escherichia coli O157: H7 infection]M Sanada, H Okano, S Yokota, et al.
Asia-Oceania Journal of Obstetrics and Gynaecology|March 1, 1994
Prenatal ultrasonographic diagnosis of congenital kyphosis due to anterior segmentation failureT B Song, Y H Kim, S T Oh, et al.
Anaesthesia|March 20, 2014
A randomised comparison of the i-gel™ and the Laryngeal Mask Airway Classic™ in infantsM-S Kim, J-T Oh, J Y Min, et al.
Brain Research|February 26, 2008
Rod differentiation factor NRL activates the expression of nuclear receptor NR2E3 to suppress the development of cone photoreceptorsEdwin C T Oh, Hong Cheng, Hong Hao, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 4, 2001
Extracellular-superoxide dismutase in cerebrospinal fluid from infants/childrenT Adachi, M Yamamoto, H Hara, et al.
Chemical & Pharmaceutical Bulletin|January 1, 1990
Lignified natural products as potential medicinal resources. I. Potentiation of hemolytic plaque-forming cell production in miceT Oh-Hara, Y Ikeda, H Sakagami, et al.
Molecules and Cells|June 13, 2000
Effects of Polycomb group mutations on the expression of Ultrabithorax in the Drosophila visceral mesodermS H Choi, C T Oh, S H Kim, et al.
Therapeutic Advances in Hematology|March 14, 2024
A phase I trial of pevonedistat in combination with ruxolitinib for the treatment of myelofibrosisTim Kong, Nicole Gaudin, Karyn Gordon, et al.
Blood Cancer Journal|October 3, 2015
Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinibA Zhou, E M Knoche, E K Engle, et al.
Pageof 56